fda glp-1 enforcement news issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 Compounding Crackdown | Double-Helix

Switching between vial sizes: what changes and what stays the same Many researchers start with smaller vials during the titration phase and move to larger vials once they find their maintenance dose

The role of IGF-1 in age-related retinal diseases is unknown

In 2024, Koniver was sanctioned by South Carolina public-health officials who found, among other things, that hed failed to maintain his registration with the Drug Enforcement Administration while prescribing controlled substances, and that hed neglected to check patient vital signs before administering ketamine

Collectively, these recent contributions argue that future GSH-centric redox sensing and nanomedical approaches should (i) incorporate organelle targeting (especially mitochondria) to exploit subcellular redox heterogeneity, (ii) embed analyte-responsive activation into both therapeutic and imaging components, (iii) combine biochemical sensing with optical or thermal engineering for spatiotemporal control, and (iv) favor clinically translatable carriers (e.g., PLGA) for delivery

By promoting weight loss, GLP-1 medications could help address both metabolic health and the associated inflammation simultaneously

Am J Surg 201 (1): 70-5 (2011) The disposition and urinary excretion pharmacokinetics of methylene blue were determined after its intravenous administration at 15 mg/kg to mature female sheep